Site is loading…
UNC Lineberger Comprehensive Cancer Center / University of North Carolina is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has participated in 9 clinical trials with 1 currently active.
Therapeutic areas: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms.
Sponsors: Astellas Pharma Global Development, Inc., Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has 9 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms.
UNC Lineberger Comprehensive Cancer Center / University of North Carolina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.